Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News

Welcome to the Cambridge Angels

Home
About Us
Who we are
Founders and Chairs
Individual Members
Emeritus Members
Corporate and Research Members
Cambridge Angels Team
Infographic
Entrepreneurs
Why Cambridge Angels?
Is Angel Investing right for you?
Investment Criteria
Application Process
Apply
Angels
Membership Information
Member portal
Angel Interviews
Portfolio
Current Portfolio
Exits
Cambridge Angels Founded Companies
Portfolio facts
Portfolio Interviews
Apply to Cambridge Angels
News
Portfolio News
Ecosystem News
Cognitant continues to drive improvements in T2D patients’ kidney health
8 November 2023
Guest User
Cognitant continues to drive improvements in T2D patients’ kidney health
Guest User
8 November 2023

Cognitant continues to drive improvements in T2D patients’ kidney health

Guest User
8 November 2023

Source:https://www.digitalhealth.net/2023/11/cognitant-continues-to-drive-improvements-in-t2d-patients-kidney-health/

Newer PostCambridge nanomedicine company raises $25m growth capital
Older PostFeebris study demonstrates impact of AI-guided virtual care
LI-In-Bug_small.png
Back to Top
Privacy
info@cambridgeangels.net